WallStSmart

Churchill Capital Corp XI (CCXI)vsYorkville Acquisition Corp. (MCGA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MCGA leads profitability with a 0.0% profit margin vs 0.0%. MCGA earns a higher WallStSmart Score of 30/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

MCGA

Avoid

30

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 5.3
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

MCGA1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$805.98M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

MCGA4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$241.00M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : MCGA

The strongest argument for MCGA centers on Debt/Equity.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : MCGA

The primary concerns for MCGA are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

MCGA is growing revenue faster at 0.0% — sustainability is the question.

CCXI generates stronger free cash flow (-326,107), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MCGA scores higher overall (30/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Yorkville Acquisition Corp.

FINANCIAL SERVICES · SHELL COMPANIES · USA

MCGA, in partnership with Yorkville Acquisition Corp., is a forward-thinking technology firm focused on enhancing operational efficiency across diverse industries, including finance, healthcare, and manufacturing. Utilizing advanced software development, data analytics, and cloud solutions enriched with artificial intelligence and machine learning, MCGA delivers tailored, scalable solutions that meet the evolving demands of its global clientele. With a commitment to innovation and strategic alignment with emerging market trends, the company is well-positioned for significant growth and value creation, making it a compelling prospect for institutional investors looking to capitalize on advancements in the technology sector.

Want to dig deeper into these stocks?